Comparison of 20x2 Gy and 12x3 Gy for whole-brain irradiation of multiple brain metastases from malignant melanoma

Dirk Rades, Lena Sehmisch, Amira Bajrovic, Stefan Janssen, Steven E. Schild

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background/Aim: Most patients with multiple brain metastases from melanoma receive whole-brain irradiation. In a previous study, doses >30 Gy resulted in better outcomes than 10x3 Gy. However, the optimal dose-fractionation regimen has not yet been defined. This study compared 20x2 Gy over four weeks, which was used in the previous study, to 12x3 Gy over two-and-a-half weeks. Patients and Methods: Eleven patients treated with 20x2 Gy for multiple brain metastases were compared to 12 patients treated with 12x3 Gy. Results: Intracerebral control rates at 6 and 12 months were 17% and 0% after 20x2 Gy vs. 42% and 11% after 12x3 Gy (p=0.28). Survival rates at 6 and 12 months were 36% and 9% after 20x2 Gy vs. 50% and 25% after 12x3 Gy (p=0.75). Conclusion: The less time-consuming regimen 12x3 Gy appeared not inferior to 20x2 Gy and a reasonable treatment option, particularly for patients with a limited life expectancy.

Original languageEnglish (US)
Pages (from-to)917-919
Number of pages3
JournalIn Vivo
Volume30
Issue number6
DOIs
StatePublished - Nov 1 2016

Fingerprint

Melanoma
Brain
Irradiation
Neoplasm Metastasis
Fractionation
Dosimetry
Dose Fractionation
Life Expectancy
Survival Rate
Therapeutics

Keywords

  • Dose-fractionation regimens
  • Intracerebral control
  • Melanoma
  • Multiple brain metastases
  • Survival
  • Whole-brain irradiation

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology

Cite this

Comparison of 20x2 Gy and 12x3 Gy for whole-brain irradiation of multiple brain metastases from malignant melanoma. / Rades, Dirk; Sehmisch, Lena; Bajrovic, Amira; Janssen, Stefan; Schild, Steven E.

In: In Vivo, Vol. 30, No. 6, 01.11.2016, p. 917-919.

Research output: Contribution to journalArticle

Rades, Dirk ; Sehmisch, Lena ; Bajrovic, Amira ; Janssen, Stefan ; Schild, Steven E. / Comparison of 20x2 Gy and 12x3 Gy for whole-brain irradiation of multiple brain metastases from malignant melanoma. In: In Vivo. 2016 ; Vol. 30, No. 6. pp. 917-919.
@article{1f306a1efe754e8c8b2501bc4dae3617,
title = "Comparison of 20x2 Gy and 12x3 Gy for whole-brain irradiation of multiple brain metastases from malignant melanoma",
abstract = "Background/Aim: Most patients with multiple brain metastases from melanoma receive whole-brain irradiation. In a previous study, doses >30 Gy resulted in better outcomes than 10x3 Gy. However, the optimal dose-fractionation regimen has not yet been defined. This study compared 20x2 Gy over four weeks, which was used in the previous study, to 12x3 Gy over two-and-a-half weeks. Patients and Methods: Eleven patients treated with 20x2 Gy for multiple brain metastases were compared to 12 patients treated with 12x3 Gy. Results: Intracerebral control rates at 6 and 12 months were 17{\%} and 0{\%} after 20x2 Gy vs. 42{\%} and 11{\%} after 12x3 Gy (p=0.28). Survival rates at 6 and 12 months were 36{\%} and 9{\%} after 20x2 Gy vs. 50{\%} and 25{\%} after 12x3 Gy (p=0.75). Conclusion: The less time-consuming regimen 12x3 Gy appeared not inferior to 20x2 Gy and a reasonable treatment option, particularly for patients with a limited life expectancy.",
keywords = "Dose-fractionation regimens, Intracerebral control, Melanoma, Multiple brain metastases, Survival, Whole-brain irradiation",
author = "Dirk Rades and Lena Sehmisch and Amira Bajrovic and Stefan Janssen and Schild, {Steven E.}",
year = "2016",
month = "11",
day = "1",
doi = "10.21873/invivo.11013",
language = "English (US)",
volume = "30",
pages = "917--919",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "6",

}

TY - JOUR

T1 - Comparison of 20x2 Gy and 12x3 Gy for whole-brain irradiation of multiple brain metastases from malignant melanoma

AU - Rades, Dirk

AU - Sehmisch, Lena

AU - Bajrovic, Amira

AU - Janssen, Stefan

AU - Schild, Steven E.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Background/Aim: Most patients with multiple brain metastases from melanoma receive whole-brain irradiation. In a previous study, doses >30 Gy resulted in better outcomes than 10x3 Gy. However, the optimal dose-fractionation regimen has not yet been defined. This study compared 20x2 Gy over four weeks, which was used in the previous study, to 12x3 Gy over two-and-a-half weeks. Patients and Methods: Eleven patients treated with 20x2 Gy for multiple brain metastases were compared to 12 patients treated with 12x3 Gy. Results: Intracerebral control rates at 6 and 12 months were 17% and 0% after 20x2 Gy vs. 42% and 11% after 12x3 Gy (p=0.28). Survival rates at 6 and 12 months were 36% and 9% after 20x2 Gy vs. 50% and 25% after 12x3 Gy (p=0.75). Conclusion: The less time-consuming regimen 12x3 Gy appeared not inferior to 20x2 Gy and a reasonable treatment option, particularly for patients with a limited life expectancy.

AB - Background/Aim: Most patients with multiple brain metastases from melanoma receive whole-brain irradiation. In a previous study, doses >30 Gy resulted in better outcomes than 10x3 Gy. However, the optimal dose-fractionation regimen has not yet been defined. This study compared 20x2 Gy over four weeks, which was used in the previous study, to 12x3 Gy over two-and-a-half weeks. Patients and Methods: Eleven patients treated with 20x2 Gy for multiple brain metastases were compared to 12 patients treated with 12x3 Gy. Results: Intracerebral control rates at 6 and 12 months were 17% and 0% after 20x2 Gy vs. 42% and 11% after 12x3 Gy (p=0.28). Survival rates at 6 and 12 months were 36% and 9% after 20x2 Gy vs. 50% and 25% after 12x3 Gy (p=0.75). Conclusion: The less time-consuming regimen 12x3 Gy appeared not inferior to 20x2 Gy and a reasonable treatment option, particularly for patients with a limited life expectancy.

KW - Dose-fractionation regimens

KW - Intracerebral control

KW - Melanoma

KW - Multiple brain metastases

KW - Survival

KW - Whole-brain irradiation

UR - http://www.scopus.com/inward/record.url?scp=84994289064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994289064&partnerID=8YFLogxK

U2 - 10.21873/invivo.11013

DO - 10.21873/invivo.11013

M3 - Article

C2 - 27815480

AN - SCOPUS:84994289064

VL - 30

SP - 917

EP - 919

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 6

ER -